Tag Archives: Detailing

Pharma's Promotional Spend: What's the Right Target?

Global consultancy Cegedim has released its latest survey on how and where big Pharma puts its promotional dollar. Pharmaceutical Promotional Spend: Global Trends reports that spending in emerging markets significantly increased last year, while Europe and US declined slightly.  Although overall promotion spending remained flat worldwide at $90 billion, the US still accounts for the […]
Posted in Advertising, Emerging Markets, Europe, Global, Marketing, Meetings, Sales, social media, Strategy, Technology | Also tagged , , , , | Leave a comment

US v. Caronia: What Constitutes 'Truthful' Speech?

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?
Posted in Advertising, compliance, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , , , , , , , , , , , | 1 Comment

Sales Rep vs. eDetail: Consider the Practice Area

Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped (or have been pushed) out, according to a survey of U.S. physicians.
Posted in Advertising, E-Media, Marketing, Sales, Strategy | Also tagged , | 2 Comments

New FDA Campaign Targets Detailing, Trade Shows

In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s […]
Posted in FDA, News, Regulatory | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta